Yale Cancer Ctr Revenue and Competitors
Estimated Revenue & Valuation
- Yale Cancer Ctr's estimated annual revenue is currently $18.2M per year.
- Yale Cancer Ctr's estimated revenue per employee is $243,000
Employee Data
- Yale Cancer Ctr has 75 Employees.
- Yale Cancer Ctr grew their employee count by 50% last year.
Yale Cancer Ctr's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Clinical Research Officer | Reveal Email/Phone |
2 | Assistant Director, Clinical Trials Operations | Reveal Email/Phone |
3 | Director CTO Operations, Clinical Trials Office | Reveal Email/Phone |
4 | Associate Cancer Center Director, Research Affairs | Reveal Email/Phone |
5 | Associate Center Director for Innovative Medicine | Reveal Email/Phone |
6 | Director RCA Shared Resource | Reveal Email/Phone |
7 | Medical Director, Adult Sickle Cell Program | Reveal Email/Phone |
8 | Associate Director, Cancer Care Equity | Reveal Email/Phone |
9 | Associate Director, Clinical Initiatives | Reveal Email/Phone |
10 | Director | Reveal Email/Phone |
Yale Cancer Ctr Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $24.3M | 90 | 7% | N/A | N/A |
#2 | $13.4M | 55 | 6% | N/A | N/A |
#3 | $21.6M | 80 | 7% | N/A | N/A |
#4 | $23.2M | 86 | 48% | N/A | N/A |
#5 | $36.5M | 135 | -6% | N/A | N/A |
#6 | $18M | 74 | 3% | N/A | N/A |
#7 | $35.6M | 132 | 11% | N/A | N/A |
#8 | $9.7M | 45 | 10% | N/A | N/A |
#9 | $28.6M | 106 | 3% | N/A | N/A |
#10 | $9.9M | 46 | 2% | N/A | N/A |
What Is Yale Cancer Ctr?
Yale Cancer Ctr is a hospital & health care company based out of 333 Cedar St, New Haven, Connecticut, United States.
keywords:N/AN/A
Total Funding
75
Number of Employees
$18.2M
Revenue (est)
50%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 77 | 28% | N/A |
#2 | $13.9M | 77 | 33% | N/A |
#3 | $7.5M | 77 | 0% | N/A |
#4 | $11.3M | 78 | N/A | N/A |
#5 | $35M | 78 | 15% | N/A |